Cargando…

Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19

Microbial translocation (MT) and intestinal damage (ID) are poorly explored in COVID-19. Aims were to assess whether alteration of gut permeability and cell integrity characterize COVID-19 patients, whether it is more pronounced in severe infections and whether it influences the development of subse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliva, Alessandra, Miele, Maria Claudia, Di Timoteo, Federica, De Angelis, Massimiliano, Mauro, Vera, Aronica, Raissa, Al Ismail, Dania, Ceccarelli, Giancarlo, Pinacchio, Claudia, d’Ettorre, Gabriella, Mascellino, Maria Teresa, Mastroianni, Claudio M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316921/ https://www.ncbi.nlm.nih.gov/pubmed/34335624 http://dx.doi.org/10.3389/fimmu.2021.708149

Ejemplares similares

Antibacterial Effectiveness of Fecal Water and In Vitro Activity of a Multi-Strain Probiotic Formulation against Multi-Drug Resistant Microorganisms
por: Oliva, Alessandra, et al.
Publicado: (2020)

Role of Serum E-Selectin as a Biomarker of Infection Severity in Coronavirus Disease 2019
por: Oliva, Alessandra, et al.
Publicado: (2021)

Preventing influenza and influenza like illness during Covid-19 pandemic: A call for action
por: d'Ettorre, Gabriele, et al.
Publicado: (2022)

Challenges in the Microbiological Diagnosis of Implant-Associated Infections: A Summary of the Current Knowledge
por: Oliva, Alessandra, et al.
Publicado: (2021)

Persistent Systemic Microbial Translocation, Inflammation, and Intestinal Damage During Clostridioides difficile Infection
por: Oliva, Alessandra, et al.
Publicado: (2019)

Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

Antiretroviral Therapy Dampens Mucosal CD4(+) T Lamina Propria Lymphocytes Immune Activation in Long-Term Treated People Living with HIV-1
por: Lazzaro, Alessandro, et al.
Publicado: (2021)

Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2019)

Microbial Translocation and Infectious Diseases: What Is the Link?
por: D'Ettorre, Gabriella, et al.
Publicado: (2012)

High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii
por: De Angelis, Massimiliano, et al.
Publicado: (2022)

Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
por: d'Ettorre, Gabriella, et al.
Publicado: (2020)

Nox2 activation in Covid-19
por: Violi, Francesco, et al.
Publicado: (2020)

Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic
por: Russo, Alessandro, et al.
Publicado: (2021)

Is previous influenza-like illness a potential Trojan horse for COVID-19?
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)

Dysbiosis in SARS-CoV-2–Infected Patients
por: Marazzato, Massimiliano, et al.
Publicado: (2021)

SARS-CoV-2 Among Migrants Recently Arrived in Europe From Low- and Middle-Income Countries: Containment Strategies and Special Features of Management in Reception Centers
por: Fabris, Silvia, et al.
Publicado: (2021)

“Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety” [Response To Letter]
por: Mascellino, Maria Teresa, et al.
Publicado: (2021)

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
por: Mascellino, Maria Teresa, et al.
Publicado: (2021)

Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021)

Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
por: Santinelli, Letizia, et al.
Publicado: (2022)

Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report
por: d’Ettorre, Gabriella, et al.
Publicado: (2020)

Probiotics and COVID-19
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)

Secondary Antibiotic Resistance, Correlation between Genotypic and Phenotypic Methods and Treatment in Helicobacter pylori Infected Patients: A Retrospective Study
por: Mascellino, Maria Teresa, et al.
Publicado: (2020)

Gut Microbial Translocation in Critically Ill Children and Effects of Supplementation with Pre- and Pro Biotics
por: Papoff, Paola, et al.
Publicado: (2012)

Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial
por: Innocenti, Giuseppe P., et al.
Publicado: (2020)

Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV‐1‐infected male patients
por: Santinelli, Letizia, et al.
Publicado: (2021)

The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit
por: Ceccarelli, Giancarlo, et al.
Publicado: (2015)

Purulent Meningitis as an Unusual Presentation of Staphylococcus aureus Endocarditis: A Case Report and Literature Review
por: Ceccarelli, Giancarlo, et al.
Publicado: (2011)

Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation
por: Pinacchio, Claudia, et al.
Publicado: (2018)

Preliminary Attempt to Predict Risk of Invasive Pulmonary Aspergillosis in Patients with Influenza: Decision Trees May Help?
por: Bellelli, Valeria, et al.
Publicado: (2020)

Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients
por: Trinchieri, Vito, et al.
Publicado: (2022)

Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature
por: Ceccarelli, Giancarlo, et al.
Publicado: (2011)

Health-related quality of life in survivors of severe COVID-19 infection
por: d’Ettorre, Gabriele, et al.
Publicado: (2022)

Is teicoplanin a complementary treatment option for COVID-19? The question remains
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)

Efficacy of Remdesivir-Containing Therapy in Hospitalized COVID-19 Patients: A Prospective Clinical Experience
por: Russo, Alessandro, et al.
Publicado: (2021)

Oxygen Sparing Effect of Bacteriotherapy in COVID-19
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021)

Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals
por: Ceccarelli, Giancarlo, et al.
Publicado: (2017)

Retinal involvement and ocular findings in COVID-19 pneumonia patients
por: Pirraglia, Maria Pia, et al.
Publicado: (2020)

Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects
por: De Angelis, Massimiliano, et al.
Publicado: (2019)

Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study
por: Scagnolari, Carolina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5le8onuf5a2cdo6ik2dl4ni6gv